These last few years, the pandemic shined a spotlight on the inequalities that exist in areas from healthcare to technology. It changed the way we interact as a society, the way we do business, practice medicine, and conduct research. Inequities in health access and outcomes are at the forefront of conversations, and its time to focus on finding solutions.
That’s why the 2022 Presidential Plenary at the IGCS Annual Global Meeting in New York will explore Collaborative Solutions to Achieve Equitable Gynecologic Cancer Care through Innovation, Research, and Advocacy.
Dr. Douglas Lowy
Acting Director and Principal Deputy Director of the National Cancer Institute and National Institutes of Health
Research Advocate on the Scientific Advisory Committee of the Ovarian Cancer Research Alliance (OCRA); incoming Chair of the NCI Council of Research Advocates; ovarian and breast cancer survivor
Dr. Tashanna Myers
Division Chief of Gynecologic Oncology at Baystate Medical Center and Member of the GOG Foundation’s Patient Advocacy and Clinical Trials Equity Committee
Dr. Robert Coleman
IGCS President and Chief Scientific Officer at US Oncology Research